JD Power Maintains 2026 New-Vehicle Sales Forecast, Asserts Ongoing Industry Resilience

Inflation eases just as fuel excise discount about to end

Can GLP-1s increase the risk of a rare eye condition?

The FDA has approved Lipfendra, the first once daily oral PCSK9 inhibitor, after trials showed it lowered LDL cholesterol by 56% to 59% in...

Helena Wright identified as mother in SA tragedy as wild weather stalls search for baby boy